For academic discoveries eschewed by traditional venture capital business models, there is now an alternative path.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Huggett, B. Nat. Biotechnol. 30, 395–400 (2012).
Frangioni, J.V. Nat. Biotechnol. 26, 503–507 (2008).
Frangioni, J.V. J. Clin. Oncol. 26, 4012–4021 (2008).
Mieog, J.S. et al. Ann. Surg. Oncol. 18, 2483–2491 (2011).
Troyan, S.L. et al. Ann. Surg. Oncol. 16, 2943–2952 (2009).
Choi, H.S. et al. Angew. Chem. Int. Edn. Engl. 50, 6258–6263 (2011).
Gioux, S., Choi, H.S. & Frangioni, J.V. Mol. Imaging 9, 237–255 (2010).
Hutteman, M. et al. Ann. Surg. Oncol. 18, 1006–1014 (2011).
Lee, B.T. et al. Plast. Reconstr. Surg. 126, 1472–1481 (2010).
van der Vorst, J.R. et al. Int. J. Gynecol. Cancer 21, 1472–1478 (2011).
I thank P. Ariniello, C. Colecchi, M. Herman, J. Hoppin, L. Keys, S. Levin, A. Lo, S. Madigan, L. Moffitt, F. Monti, J. Murgia, B. Preston, M. Rosenberg, J. Rosenbloom and M. Tweedle for many helpful discussions and L. Gendall for editing.
FLARE technology is owned by Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School, Cambridge, Massachusetts, USA. It has been licensed to the FLARE Foundation, a nonprofit organization focused on promoting the dissemination of medical imaging technology for research and clinical use. J. Frangioni is the founder and chairman of the FLARE Foundation. The Beth Israel Deaconess Medical Center will receive royalties for sale of FLARE Technology. J. Frangioni has elected to surrender post-market royalties to which he would otherwise be entitled as inventor and has elected to donate pre-market proceeds to the FLARE Foundation. J. Frangioni has started three for-profit companies, Curadel, Curadel Medical Devices and Curadel In Vivo Diagnostics, which may someday be non-exclusive sublicensees of FLARE technology.
About this article
Cite this article
Frangioni, J. Nonprofit foundations for open-source biomedical technology development. Nat Biotechnol 30, 928–932 (2012). https://doi.org/10.1038/nbt.2392
This article is cited by
Nature Biomedical Engineering (2017)